Adjunctive donepezil in attention deficit hyperactivity disorder youth: Case series

Timothy E. Wilens, Joseph Biederman, Jocelyn Wong, Thomas J. Spencer, Jeffrey B. Prince

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

Despite well-documented improvement in attention deficit hyperactivity disorder (ADHD) in youths with the available single and combined pharmacologic agents, a number of youths remain with residual symptomatology causing impairment in multiple domains. Recent work has suggested a potential cognitive-enhancing role of cholinergic agents in ADHD. We describe five cases of ADHD youths aged 8-17 years being treated for ADHD with the acetylcholinesterase inhibitor donepezil (Aricept®), all of whom demonstrated improvement.

Original languageEnglish (US)
Pages (from-to)217-222
Number of pages6
JournalJournal of child and adolescent psychopharmacology
Volume10
Issue number3
DOIs
StatePublished - 2000

Fingerprint Dive into the research topics of 'Adjunctive donepezil in attention deficit hyperactivity disorder youth: Case series'. Together they form a unique fingerprint.

Cite this